Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
143 participants
INTERVENTIONAL
2022-04-04
2025-06-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Speech Signals in Stuttering
NCT05668923
Auditory Prediction and Error Evaluation in the Speech of Individuals Who Stutter
NCT06181149
Network Connectivity and Temporal Processing in Adolescents Who Stutter
NCT05286151
Effects of Emotional Processes on Speech Motor Control in Early Childhood Stuttering.
NCT05003583
The Development of Stuttering in Young Children
NCT06578416
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adults who stutter (AWS)
Participants will have 2 visits.
Speech and non-speech tasks
Participants will complete speech tasks such as listening to and/or producing speech and non-speech sounds.
Healthy Adults
Participants will have 2 visits.
Speech and non-speech tasks
Participants will complete speech tasks such as listening to and/or producing speech and non-speech sounds.
Children who Stutter
Participants will have 1 visit.
Speech and non-speech tasks
Participants will complete speech tasks such as listening to and/or producing speech and non-speech sounds.
Healthy Children
Participants will have 1 visit.
Speech and non-speech tasks
Participants will complete speech tasks such as listening to and/or producing speech and non-speech sounds.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Speech and non-speech tasks
Participants will complete speech tasks such as listening to and/or producing speech and non-speech sounds.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English as primary language
* Normal speech, language, hearing, cognition
* Aged 18-65 years
* English as primary language
* Normal speech, language, hearing, cognition (other than stuttering)
* Currently stutters
* Aged 6 to 17 years
* English as primary language
* Normal speech, language, hearing, cognition
* Aged 6 to 17 years
* English as primary language
* Normal speech, language, hearing, cognition (other than stuttering)
* Currently stutters
Exclusion Criteria
* Major medical or psychiatric illness
* Speech therapy within the past year
* Major medical or psychiatric illness
* Personal or family history of stuttering
* Major medical or psychiatric illness
* Language/motor delay
* Major medical or psychiatric illness
* Language/motor delay
6 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Deafness and Other Communication Disorders (NIDCD)
NIH
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emily O'Dell Garnett
Research Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emily Garnett, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Michigan
Ann Arbor, Michigan, United States
Michigan State University
East Lansing, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUM00194953
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.